LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.
Registrars:
Key Personnel
CEO:
Paul Carmelo Pagano
Non-Executive Director:
Sara Barrington
Non-Executive Chairman:
Gordon Roy Davis
Senior Independent Non-Executive Director:
Andrew Norman Boteler
Chief Finance Officer:
David Mark Anderson
Contact Details
Address:
850 New Burton Road, Suite 201, Dover, Delaware, USA